Diabetes and Endocrinology

Episodes 1-14 of 14

• • 

    

    Angel O. Coz Yataco, MD, FCCP

    Peer

  • 

    

    Julio A. Ramírez, MD, FACP

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  1

  

  RestartResume

  Ciencia Emergente en Pacientes de Alto Riesgo: Selección Apropiada de Terapia Antiviral Contra la Influenza

  RestartResume

  Ciencia Emergente en Pacientes de Alto Riesgo: Selección Apropiada de Terapia Antiviral Contra la Influenza

  0.25 credits

  Ciencia Emergente en Pacientes de Alto Riesgo: Selección Apropiada de Terapia...

  0.25 credits

• • 

    

    Christopher P. Cannon, MD

    Peer

  • 

    

    Samuel Dagogo-Jack, MD, DSc

    Peer

  11

  

  RestartResume

  Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?

  RestartResume

  Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?

  0.25 credits

  Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients wit...

  0.25 credits

• • 

    

    Barnett Mennen, MD

    Peer

  • 

    

    Sarah Hallberg, MD

    Peer

  31

  

  RestartResume

  Is a Low-Carb, High-Fat Diet the Key to Diabetic Management?

  RestartResume

  Is a Low-Carb, High-Fat Diet the Key to Diabetic Management?

  Is a Low-Carb, High-Fat Diet the Key to Diabetic Management?
• 2

  

  RestartResume

  Home Monitoring of Blood Sugar Did Not Improve Glycemic Control After 1 Year

  RestartResume

  Home Monitoring of Blood Sugar Did Not Improve Glycemic Control After 1 Year

  Home Monitoring of Blood Sugar Did Not Improve Glycemic Control After 1 Year

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Charles N. Walker, MD

    Peer

  12

  

  RestartResume

  Managing Erectile Dysfunction Stemming from Diabetes and Heart Disease

  RestartResume

  Managing Erectile Dysfunction Stemming from Diabetes and Heart Disease

  Managing Erectile Dysfunction Stemming from Diabetes and Heart Disease
• 22

  

  RestartResume

  Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods

  RestartResume

  Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods

  Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods
• 11

  

  RestartResume

  Injectable Medication as an Alternative Treatment for Diabetic Eye Disease

  RestartResume

  Injectable Medication as an Alternative Treatment for Diabetic Eye Disease

  Injectable Medication as an Alternative Treatment for Diabetic Eye Disease
• 17

  

  RestartResume

  Study Finds Diabetes in the United States Continues to Rise

  RestartResume

  Study Finds Diabetes in the United States Continues to Rise

  Study Finds Diabetes in the United States Continues to Rise
• 4

  

  RestartResume

  Testosterone Therapy Neither Advances Nor Slows Down Hardening of the Arteries in Older Men with Low Testosterone Levels

  RestartResume

  Testosterone Therapy Neither Advances Nor Slows Down Hardening of the Arteries in Older Men with Low Testosterone Levels

  Testosterone Therapy Neither Advances Nor Slows Down Hardening of the Arterie...

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Candis Morello, PharmD, CDE

    Peer

  38

  

  RestartResume

  The Role of the Certified Diabetes Educator: A Team Effort

  RestartResume

  The Role of the Certified Diabetes Educator: A Team Effort

  The Role of the Certified Diabetes Educator: A Team Effort

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Candis Morello, PharmD, CDE

    Peer

  21

  

  RestartResume

  Toward a Healthier Journey for the Type 2 Diabetes Patient

  RestartResume

  Toward a Healthier Journey for the Type 2 Diabetes Patient

  Toward a Healthier Journey for the Type 2 Diabetes Patient

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Neil Skolnik, MD

    Peer

  43

  

  RestartResume

  Fostering a "Back to Basics" Model in Type 2 Diabetes Care

  RestartResume

  Fostering a "Back to Basics" Model in Type 2 Diabetes Care

  Fostering a "Back to Basics" Model in Type 2 Diabetes Care

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Meryl S. LeBoff, MD

    Peer

  29

  

  RestartResume

  Shattering Myths About Osteoporosis

  RestartResume

  Shattering Myths About Osteoporosis

  Shattering Myths About Osteoporosis

• • 

    

    Lutz Heinemann, PhD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  6

  

  RestartResume

  How Similar are Biosimilar Insulins?

  RestartResume

  How Similar are Biosimilar Insulins?

  How Similar are Biosimilar Insulins?